The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Practical Medication Management

Practical Medication Management

September 1, 2009 • By Gretchen Henkel

  • Tweet
  • Email
Print-Friendly Version / Save PDF

SAN FRANCISCO—With little clinical evidence to guide them, rheumatologists often struggle to select appropriate treatments for their patients with special issues, noted moderator Peter J. Embi, MD, MS, assistant professor of medicine at the University of Cincinnati, as he introduced presenters in the 2008 ACR/ARHP Annual Scientific Meeting session, “Practical Pharmacotherapy: Special Problems in Special Patient Populations.” Accordingly, he and co-moderator Michael H. Weisman, MD, director of the Division of Rheumatology at Cedars-Sinai Medical Center in Los Angeles, chose two knowledgeable presenters: Stephen A. Paget, MD, physician-in-chief and chairman of the Division of Rheumatology at the Hospital for Special Surgery (HSS) in New York; and Carl A. Laskin, MD, Rheumatic Disease Unit, University of Toronto, and director, LifeQuest Centre for Reproductive Medicine. Both offered guidance from their own experience.

You Might Also Like
  • Diagnosis, Management of Medication-Induced Osteonecrosis of the Bone
  • Rheumatology Fellowship Work in Ethiopia Reveals Gaps in Practical Management of Rheumatic Diseases
  • Flare Risk Increases When Medication Is Stopped Prior to Arthroplasty
Explore This Issue
September 2009
Also By This Author
  • For MAS, Early Diagnosis Is Key

Perioperative Care: A Balancing Act

In patients with arthritis undergoing joint replacements, physicians must balance the medications taken to control disease processes with the need to ensure optimal wound healing, Dr. Paget emphasized. Preventing flareups may help to ensure successful postsurgical rehabilitation. With nearly 1 million combined total knee and total hip replacements performed in the United States each year, these benefit–risk challenges are apt to increase.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

At the HSS, rheumatologists are members of a multidisciplinary team. Decisions about continuing or withdrawing drug therapy are considered in the context of such questions as: Will the medications affect healing of soft tissues and bone? Will they increase the risk of infection? Will the medication improve overall short- and long-term outcome of the surgery—and does this effect differ with different types of surgery?

Dr. Paget combined a literature review with the HSS experience regarding use of antirheumatic therapies—nonsteroidal antiinflammatory drugs (NSAIDs), corticosteroids, and biologic and non-biologic disease-modifying antirheumatic drugs (DMARDs)—in the perioperative setting and included a discussion of bisphosphonates and osteoporosis medications. He acknowledged that some of his advice may not be within the comfort zone of some rheumatologists. For instance, he said, “At the HSS, we do not avoid or discontinue NSAIDs of any kind before surgery—except for spine surgery, where they carry a risk of non-union.” Perioperative aspirin is also usually continued for primary coronary prevention as well as pain management. Results with this approach have been uniformly positive, he said, with no increased incidence of bleeding problems.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Paget also presented practical guidance regarding perioperative steroid coverage for patients on chronic steroid therapies ranging from 5 mg or less per day to 5 to 7.5 mg per day. As corticosteroids may predispose the patient to wound healing problems, this risk must be carefully balanced with the need for stress doses, he said. Wound healing issues also surface in patients taking methotrexate. Most prospective and retrospective studies suggest that the drug can be continued during the perioperative period without impairing wound healing or increasing infection risk. However, patients with diabetes or a history of infection demand a different approach—for example, stopping the drug two weeks prior to surgery and resuming two weeks afterwards, providing there is good wound healing.

Pages: 1 2 3 4 | Single Page

Filed Under: Practice Management Tagged With: Clinical, Practice, Quality CareIssue: September 2009

You Might Also Like:
  • Diagnosis, Management of Medication-Induced Osteonecrosis of the Bone
  • Rheumatology Fellowship Work in Ethiopia Reveals Gaps in Practical Management of Rheumatic Diseases
  • Flare Risk Increases When Medication Is Stopped Prior to Arthroplasty
  • Practical Advice for the Rheumatologist on Medicare PQRI

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)